Publication | Closed Access

A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee

Pain MedicinePhase Iii TrialChronic Musculoskeletal ConditionOsteoarthritisOrthopaedicsPain ManagementMedicineOrthopaedic SurgeryNon-operative Treatment